PSP Research »

Oric Pharmaceuticals shares owned by PSP Research

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $165k 13k 12.67

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
Viking Global Investors
BlackRock
VR Adviser
Pfizer
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
State Street Corporation
NEA Management Company
OrbiMed Advisors
Column Group
Point72 Asset Management
FMR

View all funds holding Oric Pharmaceuticals